- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02701920
HeartLight: Heart Rate Monitoring for Newborn Resuscitation (HeartLight)
Study Overview
Status
Conditions
Detailed Description
Up to 10% of newborns require some form of resuscitation at birth. Heart rate (HR) is the most sensitive indicator of resuscitation efficacy. HR is most commonly estimated using a stethoscope. However, in simulation studies it has been shown that newborn healthcare providers estimate HR incorrectly in up to 1/3 of cases. Common techniques for monitoring heart rate such as electrocardiography (ECG) and pulse oximetry (PO) were not developed for resuscitation at birth.
ECG, an established and accurate method of monitoring HR, is rarely used in the delivery room for a number of reasons including difficulty ensuring adhesion to the skin (the baby is wet/covered in vernix) and skin damage in premature babies caused by stripping of the electrodes. Current ECG systems also require 3 electrodes to be positioned which can delay resuscitation further. The usual site for transmission PO is the foot or hand. However, in newborn babies, and particularly those requiring resuscitation when the HR is low, blood flow is reduced so physiological mechanisms preserve brain and heart blood flow at the expense of other less important organs and limbs. As a consequence of this and the choice of wavelengths, it can be more difficult to obtain a reliable HR from POs on the limbs, and they typically obtain an HR after 1-2 minutes.
In the delivery room, ECG and PO systems have a requirement for cables to connect to the main monitors. These can get in the way and it is now recommended for many babies to delay cutting the umbilical cord (to ensure more blood enters the baby from the placenta) which often requires the baby to be resuscitated very close to the mother and even between their legs.
The HeartLight system is a wireless optical sensor within a custom newborn hat to allow quick and accurate HR monitoring. It will be compared to ECG, PO and electronic stethoscope to determine the accuracy and reliability. The trial has 4 phases; Phase 1 evaluates the thermal properties of the hat, Phase 2 evaluates the accuracy and reliability of the HeartLight sensor on babies within the Neonatal Intensive Care Unit environment, Phase 3 evaluates the HeartLight sensor in newborn babies born by cesarean section and Phase 4 evaluates the performance of the HeartLight sensor in babies of all gestations requiring resuscitation and stabilisation at birth.
The investigators anticipate the HeartLight sensor and hat will allow swift and effective deployment, reduce delays in resuscitation (due to using a stethoscope) and improve HR accuracy (as a result of avoiding errors in the usual manual mental calculations made in the stressful environment of the delivery room) when it is needed most. However, an additional benefit is that it will not require significant modification to the existing care pathway or resuscitation protocols, and therefore a potential barrier to clinical uptake is removed.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Nottingham, United Kingdom, NG72UH
- University of Nottingham NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Written consent from the mother
- Realistic prospect of survival as determined by the attending clinical team
Phase 1:
- Infants on NICU
Phase 2:
- Infants on NICU requiring heart rate monitoring
Phase 3:
- Newborn infants following non-emergency elective cesarean section
Phase 4:
- Newborn infants who attending clinical team anticipate will require assessment of heart rate at time of birth
Feedback:
- Mothers of babies recruited into HeartLight study
- Healthcare professionals exposed to the new device
Exclusion Criteria:
Phase 1+2:
- Infants undergoing palliative care
- Infants too sick to tolerate additional procedures
Phase 3:
- Abnormal antenatal scans suggesting significant fetal abnormality (by definition these are not routine pregnancies).
- Any infant in whom resuscitation is likely to be required.
- If multiple births then only the first baby born shall be recruited (due to resource limitations with researchers attending the birth)
Phase 4:
- Infants <23 weeks
- Infants that are not for active resuscitation as decided by the clinical team
- If multiple births then only the first baby born shall be recruited (due to resource limitations with researchers attending the birth)
Feedback:
Unable to obtain written informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
NICU infants and hat
Newborn infants of any gestation on the neonatal intensive care unit (NICU).
|
HeartLight hat will be worn for up to 1 hour.
The HeartLight hat with in-built sensor will be worn.
|
NICU infants and sensor
Newborn infants of any gestation requiring heart rate monitoring on the neonatal intensive care unit.
|
The HeartLight hat with in-built sensor will be worn.
Electronic stethoscope will be used to estimate heart rate with HeartLight sensor/hat
HeartLight sensor/hat will be used with ECG/Pulse oximetry/electronic stethoscope
|
Newborns and surgical delivery
Well term newborn infants following birth by cesarean section.
|
The HeartLight hat with in-built sensor will be worn.
Electronic stethoscope will be used to estimate heart rate with HeartLight sensor/hat
HeartLight sensor/hat will be used with ECG/Pulse oximetry/electronic stethoscope
|
Newborns needing stabilisation
Newborn infants requiring resuscitation or stabilisation following birth.
|
Electronic stethoscope will be used to estimate heart rate with HeartLight sensor/hat
HeartLight sensor/hat will be used with ECG/Pulse oximetry/electronic stethoscope
|
Parental feedback
Parental feedback of babies recruited into HeartLight will be sought.
|
Questionnaire
|
Healthcare provider feedback
Healthcare professionals caring for babies recruited into HeartLight will have their feedback on the device sought.
|
Questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart Rate acquisition time in the first minute of life
Time Frame: 1 hour
|
Time to acquire heart rate from new optical hat sensor from birth should be within 1 minute of birth.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reliability of heart rate generated by HeartLight device
Time Frame: 1 hour
|
Assess the reliability of the new heart rate device
|
1 hour
|
Accuracy of heart rate generated by HeartLight device
Time Frame: 1 hour
|
Assess the accuracy of the new heart rate device
|
1 hour
|
Feedback on acceptability of hat and device
Time Frame: 1 hour
|
Feedback will be recorded via a questionnaire from both healthcare professionals and mothers.
|
1 hour
|
Thermal imaging to determine heat loss whilst wearing hat
Time Frame: 1 hour
|
Participants will be thermal imaged whilst wearing the hat to determine heat loss.
|
1 hour
|
Thermal imaging to determine heat loss during stabilisation and/or resuscitation
Time Frame: 1 hour
|
Participants will be thermal imaged during stabilisation and/or resuscitation whilst wearing the hat to determine heat loss.
|
1 hour
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Don Sharkey, PhD, University of Nottingham
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15099
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Newborn, Diseases
-
The Baruch Padeh Medical Center, PoriyaTerminatedInfant | Newborn Diseases
-
Abbott NutritionInstitute of Child HealthCompleted
-
ARCIM Institute Academic Research in Complementary...University Hospital TuebingenCompleted
-
University of RochesterThe Commonwealth Fund; Academic Pediatric AssociationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedInfant, Newborn, DiseaseFrance
-
King's College LondonKing's College Hospital NHS TrustCompletedInfant, Newborn, DiseaseUnited Kingdom
-
Federal State Budget Institution Research Center...Recruiting
-
Ataturk UniversityMSc Elif Simay KOÇCompleted
-
Comenius UniversityActive, not recruitingInfant, NewbornSlovakia
-
Centre Hospitalier Universitaire, AmiensCompleted
Clinical Trials on HeartLight hat
-
CardioFocusCompletedAtrial FibrillationCzechia
-
CardioFocusCompletedAtrial FibrillationCzechia
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Prof. Dr. med. Bernd LemkeUnknownPersistent Atrial FibrillationGermany
-
Cardioangiologisches Centrum BethanienCompletedAtrial FibrillationGermany
-
Sorin Group USA, Inc.TerminatedAortic Valve DiseaseUnited States
-
University of South FloridaCompleted
-
CardioFocusCompletedParoxysmal Atrial FibrillationUnited States
-
Hospital Universitari de BellvitgeRecruitingVascular Diseases | Arteriovenous FistulaSpain